The relationship between the prognosis of children with acute arterial stroke and polymorphisms of CDKN2B, HDAC9, NINJ2, NAA25 genes.


Journal

Journal of thrombosis and thrombolysis
ISSN: 1573-742X
Titre abrégé: J Thromb Thrombolysis
Pays: Netherlands
ID NLM: 9502018

Informations de publication

Date de publication:
May 2019
Historique:
pubmed: 19 1 2019
medline: 14 8 2019
entrez: 19 1 2019
Statut: ppublish

Résumé

Ischemic stroke is a significant health condition, whose frequency in childhood is increasing day by day. Although many factors are effective in development of the stroke, it has been showed that individuals having risk factors have a genetic predisposition. The aim of the study is to determine whether distinct genetic mutations are risk factors for children with history of ischemic stroke. Our sample data is taken from 58 patients (29 male and 29 female) who applied our hospital between 2012 and 2016 with diagnosis of acute or chronic arterial stroke and from 70 healthy children (32 male and 38 female) with similar particularities in the sense of age and sex, who have not any chronical disease. Blood samples are taken from each child participated in the study to conduct genetic analysis. It has been examined whether a mutation exists in gene locations of CDKN2B-AS1 (Rs2383206), HDAC9 (Rs11984041), NINJ2 (Rs12425791), NAA25 (Rs17696736). Moreover, whether there are significant difference between patient and control group has been investigated. In the genetic analysis of patients and control groups, no significant difference has been found for any of the genes. Mutations in gene locations of CDKN2B-AS1 (Rs2383206), HDAC9 (Rs11984041), NINJ2 (Rs12425791), NAA25 (Rs17696736) are not risk factors for ischemic stroke in childhood. However this study showed us, the patients who inherit CDKN2B-AS1 and HDCA9 gene mutations had poor prognosis. However, this study should be replicated for a wider sample of patient population.

Identifiants

pubmed: 30656483
doi: 10.1007/s11239-018-01802-9
pii: 10.1007/s11239-018-01802-9
doi:

Substances chimiques

CDKN2B protein, human 0
Cell Adhesion Molecules, Neuronal 0
Cyclin-Dependent Kinase Inhibitor p15 0
NAA25 protein, human 0
NINJ2 protein, human 0
Repressor Proteins 0
N-Terminal Acetyltransferase B EC 2.3.1.255
HDAC9 protein, human EC 3.5.1.98
Histone Deacetylases EC 3.5.1.98

Types de publication

Clinical Trial Journal Article

Langues

eng

Pagination

578-584

Références

J Neurosci. 2000 Jan 1;20(1):187-95
pubmed: 10627596
Dev Med Child Neurol. 2000 Jul;42(7):455-61
pubmed: 10972417
Pediatr Neurol. 2003 Feb;28(2):134-8
pubmed: 12699865
Curr Neurol Neurosci Rep. 2004 Mar;4(2):129-38
pubmed: 14984685
Med Princ Pract. 2004 May-Jun;13(3):153-8
pubmed: 15073428
Science. 2007 Jun 8;316(5830):1488-91
pubmed: 17478681
Stroke. 2007 Oct;38(10):e111
pubmed: 17717303
Childs Nerv Syst. 2008 Sep;24(9):983-6
pubmed: 18481071
J Hypertens. 2009 Apr;27(4):769-73
pubmed: 19293724
Acta Paediatr. 2009 Oct;98(10):1613-9
pubmed: 19594463
Pediatr Neurol. 2009 Oct;41(4):247-9
pubmed: 19748043
Circ Cardiovasc Genet. 2008 Dec;1(2):81-4
pubmed: 20031549
Stroke. 2010 Jun;41(6):1123-31
pubmed: 20395606
N Engl J Med. 2010 Apr 22;362(16):1547-50
pubmed: 20410525
J Clin Neurosci. 2010 Aug;17(8):1000-2
pubmed: 20537898
Ann Neurol. 2011 Jan;69(1):130-40
pubmed: 21280083
Pediatr Neurol. 2011 Sep;45(3):155-8
pubmed: 21824561
PLoS Med. 2011 Oct;8(10):e1001106
pubmed: 22022235
J Neurol Sci. 2012 May 15;316(1-2):116-21
pubmed: 22297388
BMC Res Notes. 2012 Mar 20;5:155
pubmed: 22429733
Pediatr Neurol. 2012 Aug;47(2):114-8
pubmed: 22759687
BMC Med. 2012 Jul 09;10:70
pubmed: 22776031
Stroke. 2013 May;44(5):1220-5
pubmed: 23449258
Stroke. 2013 Jun;44(6 Suppl 1):S20-2
pubmed: 23709717
Pediatr Neurol. 2014 Jun;50(6):595-600
pubmed: 24842257
Circ Cardiovasc Genet. 2014 Jun;7(3):383-92
pubmed: 24951665
Clin Pediatr (Phila). 2015 Jan;54(1):40-6
pubmed: 25049311
J Stroke. 2014 Sep;16(3):114-23
pubmed: 25328870
Int J Clin Exp Med. 2015 Jan 15;8(1):1315-23
pubmed: 25785132
Brain Dev. 2016 Feb;38(2):204-8
pubmed: 26341288
J Neurosci Rural Pract. 2015 Oct-Dec;6(4):515-9
pubmed: 26752895
Neurology. 2016 Mar 29;86(13):1217-26
pubmed: 26935894
Adv Biomed Res. 2016 Jun 08;5:107
pubmed: 27376046
Pharmacogenet Genomics. 2016 Nov;26(11):497-504
pubmed: 27602548
Childs Nerv Syst. 2018 Apr;34(4):655-661
pubmed: 29209887
Bull World Health Organ. 1980;58(1):113-30
pubmed: 6966542

Auteurs

Adil Bozpolat (A)

Division of Pediatric Hematology and Oncology, Department of Pediatrics, Faculty of Medicine, Erciyes University, Melikgazi, 38039, Kayseri, Turkey.

Ekrem Unal (E)

Division of Pediatric Hematology and Oncology, Department of Pediatrics, Faculty of Medicine, Erciyes University, Melikgazi, 38039, Kayseri, Turkey. drekremunal@yahoo.com.tr.
Molecular Biology and Genetic Department, Genome and Stem Cell Center (GENKOK), Gevher Nesibe Genom and Stem Cell Institution, Erciyes University, Melikgazi, 38039, Kayseri, Turkey. drekremunal@yahoo.com.tr.

Tugba Topaloglu (T)

Department of Medical Genetics, Faculty of Medicine, Erciyes University, Kayseri, Turkey.
Betul-Ziya Eren Genome and Stem Cell Center (GENKOK), Erciyes University Medical Faculty, Kayseri, Turkey.

Serpil Taheri (S)

Department of Medical Genetics, Faculty of Medicine, Erciyes University, Kayseri, Turkey.
Betul-Ziya Eren Genome and Stem Cell Center (GENKOK), Erciyes University Medical Faculty, Kayseri, Turkey.

Ayse Kacar Bayram (AK)

Division of Pediatric Neurology, Department of Pediatrics, Faculty of Medicine, Erciyes University, Kayseri, Turkey.

Alper Ozcan (A)

Division of Pediatric Hematology and Oncology, Department of Pediatrics, Faculty of Medicine, Erciyes University, Melikgazi, 38039, Kayseri, Turkey.

Musa Karakukcu (M)

Division of Pediatric Hematology and Oncology, Department of Pediatrics, Faculty of Medicine, Erciyes University, Melikgazi, 38039, Kayseri, Turkey.

Mehmet Akif Ozdemir (MA)

Division of Pediatric Hematology and Oncology, Department of Pediatrics, Faculty of Medicine, Erciyes University, Melikgazi, 38039, Kayseri, Turkey.

Huseyin Per (H)

Betul-Ziya Eren Genome and Stem Cell Center (GENKOK), Erciyes University Medical Faculty, Kayseri, Turkey. huseyinper@yahoo.com.
Division of Pediatric Neurology, Department of Pediatrics, Faculty of Medicine, Erciyes University, Kayseri, Turkey. huseyinper@yahoo.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH